If the odds of needle tract seeding are .5% to 5.0%, this suggests that prostate biopsies should be used VERY SPARINGLY. Since PSA test results lead to many unnecessary biopsies being performed, many men are exposed to this risk.
In my case, it appears that my prostate cancer would still be confined to the prostate capsule, except that I had the prostate biopsy three years ago. Of course, the only way to prove that needle tract seeding occured is via an autopsy. That’s the interesting thing about proving that needle tract seeding occurs: the evidence is destroyed during surgical removal. And I doubt that many autopsies look for needle tract seeding. Be assured, mine will.
Why do you think urologists turn a blind eye to this risk? Could it be that without PSA tests and needle biopsies showing that men have prostate cancer, they would lose a lot of cash flow business in the form of radical prostatectomies? BTW, only 3% of men die of prostate cancer because it is usually confined to the prostate capsule and very slow-growing.
The medical community needs to rethink the needle tract seeding risk in the context of prostate cancer and the characteristics of prostate cancer. I only wish that my urologist had told me about this risk. FYI, I asked and got the same answer that you gave me on the Internet, i.e. the wrong answer.